Maria Foss de Freitas

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY”.

Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY

Diabetes Care(2024)10.2337/dc24-0730

N/A

0DataRank · unranked

9 citations

Alina Mehdi, Colby Chase, Maria Foss de Freitas, Brigid Gregg, Elif A Oral +2 more

Changes After Leptin Administration in Partial Lipodystrophy and Factors Associated With Hepatic and Metabolic Response

Journal of the Endocrine Society(2025)10.1210/jendso/bvaf067

N/A

0DataRank · unranked

2 citations

Nevin Ajluni, Rasimcan Meral, Adam Neidert, Maria Foss de Freitas, Donatella Gilio +3 more

Altered lipid metabolism and inflammatory programs associate with adipocyte loss in familial partial lipodystrophy 2

Journal of Clinical Investigation(2025)10.1172/jci198387

N/A

0DataRank · unranked

2 citations

Rebecca L. Schill, Akira Nishii, Maria Foss de Freitas, Bonje Obua, Marcus Nygård +24 more

Use of Dual GIP/GLP-1 RA in HNF1A-MODY and HNF4A-MODY

Deep Blue (University of Michigan)(2025)10.7302/25164

N/A

0DataRank · unranked

0 citations

Alina Mehdi, Colby Chase, Maria Foss de Freitas, Brigid Gregg, Elif A Oral +2 more